Stellence Pharmscience Profile
Key Indicators
- Authorised Capital ₹ 85.00 Cr
as on 17-01-2025
- Paid Up Capital ₹ 43.00 Cr
as on 17-01-2025
- Company Age 33 Year, 18 Days
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 38.00 Cr
as on 17-01-2025
- Satisfied Charges ₹ 31.92 Cr
as on 17-01-2025
- Revenue -16.45%
(FY 2022)
- Profit -521.80%
(FY 2022)
- Ebitda -53.95%
(FY 2022)
- Net Worth 25.01%
(FY 2022)
- Total Assets 12.22%
(FY 2022)
About Stellence Pharmscience
- CIN/LLPIN
U85110KA1992PTC012673
- Company No.
012673
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jan 1992
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Stellence Pharmscience Private Limited offer?
Stellence Pharmscience Private Limited offers a wide range of products and services, including Product Engineering and Prototyping, Electronics Manufacturing Service, Chemical Intermediates, Para Nitro Benzoic Acid, Industrial Chemicals & Supplies, Industrial Chemicals, Business Planning and Management, Business Consultant, Speciality Chemicals, Isophthalic Acid.
Who are the key members and board of directors at Stellence Pharmscience?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramachandran Radhakrishnan  | Managing Director | 23-Aug-2006 | Current |
| Sumit Singh | Company Secretary | 28-Sep-2023 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anuradha Ramachandran | Director | 15-May-2019 | Current |
| Akash Mathur | Director | 01-Apr-2020 | Current |
| Lalit Yadav | Director | 01-Apr-2020 | Current |
Financial Performance of Stellence Pharmscience.
Stellence Pharmscience Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 16.45% decrease. The company also saw a substantial fall in profitability, with a 521.8% decrease in profit. The company's net worth Soared by an impressive increase of 25.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Stellence Pharmscience?
In 2022, Stellence Pharmscience had a promoter holding of 99.67% and a public holding of 0.32%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
East West Handling And Distribution Private LimitedActive 19 years 5 monthsAnuradha Ramachandran is a mutual person
Avigna Chemitech Private LimitedActive 19 years 10 monthsRamachandran Radhakrishnan and Anuradha Ramachandran are mutual person
Peptyde Tx Private LimitedActive 2 years 10 monthsRamachandran Radhakrishnan and Akash Mathur are mutual person
- Svashmi Genotech Private LimitedActive 4 years 5 months
Ramachandran Radhakrishnan and Akash Mathur are mutual person
- Avigna Learning Academy Private LimitedActive 3 years 7 months
Anuradha Ramachandran is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Tata Capital Financial Services Limited Creation Date: 30 Jun 2017 | ₹7.50 Cr | Open |
Religare Finvest Limited Creation Date: 28 Jul 2015 | ₹4.00 Cr | Open |
Religare Finvest Limited Creation Date: 05 May 2015 | ₹1.43 Cr | Open |
How Many Employees Work at Stellence Pharmscience?
Stellence Pharmscience has a workforce of 103 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Stellence Pharmscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stellence Pharmscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
